KDventures announces that Organon has discontinued the development of the previous portfolio company Forendos’ drug candidate for PCOS - The Manila Times
KDventures announces that Organon has discontinued the development of the previous portfolio company Forendos’ drug candidate for PCOS The Manila Times
'A culture in which pain, fatigue and discomfort are frequently normalised' – Menstrual disorders can disrupt lives and careers, so why do we know so little about conditions like PCOS and endometriosis in cycling? - Cyclingnews
'A culture in which pain, fatigue and discomfort are frequently normalised' – Menstrual disorders can disrupt lives and careers, so why do we know so little about conditions like PCOS …